0000890821-22-000001.txt : 20220805 0000890821-22-000001.hdr.sgml : 20220805 20220805153528 ACCESSION NUMBER: 0000890821-22-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20220805 DATE AS OF CHANGE: 20220805 EFFECTIVENESS DATE: 20220805 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Enveric Biosciences, Inc. CENTRAL INDEX KEY: 0000890821 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 954484725 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-455082 FILM NUMBER: 221140503 BUSINESS ADDRESS: STREET 1: 4851 TAMIAMI TRAIL N, SUITE 200 CITY: NAPLES STATE: FL ZIP: 34103 BUSINESS PHONE: 239-302-1707 MAIL ADDRESS: STREET 1: 4851 TAMIAMI TRAIL N, SUITE 200 CITY: NAPLES STATE: FL ZIP: 34103 FORMER COMPANY: FORMER CONFORMED NAME: AMERI Holdings, Inc. DATE OF NAME CHANGE: 20150527 FORMER COMPANY: FORMER CONFORMED NAME: SPATIALIZER AUDIO LABORATORIES INC DATE OF NAME CHANGE: 19950323 D 1 primary_doc.xml X0708 D LIVE 0000890821 Enveric Biosciences, Inc. 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL FLORIDA 34103 239-302-1707 DELAWARE AMERI Holdings, Inc. SPATIALIZER AUDIO LABORATORIES INC Corporation true Joseph Tucker, PhD 4851 Tamiami Trail N Suite 200 Naples FL FLORIDA 34103 Executive Officer Director Chief Executive Officer and Director David Johnson 4851 Tamiami Trail N Suite 200 Naples FL FLORIDA 34103 Executive Officer Director Chairman Carter Ward 4851 Tamiami Trail N Suite 200 Naples FL FLORIDA 34103 Executive Officer Chief Financial Officer Avani Kanubaddi 4851 Tamiami Trail N Suite 200 Naples FL FLORIDA 34103 Executive Officer President and Chief Operating Officer George Kegler 4851 Tamiami Trail N Suite 200 Naples FL FLORIDA 34103 Director Sol Mayer 4851 Tamiami Trail N Suite 200 Naples FL FLORIDA 34103 Director Dr. Bob Dagher 4851 Tamiami Trail N Suite 200 Naples FL FLORIDA 34103 Executive Officer Chief Medical Officer Peter Facchini, PhD 4851 Tamiami Trail N Suite 200 Naples FL FLORIDA 34103 Executive Officer Chief Innovation Officer Dr. Douglas Lind 4851 Tamiami Trail N Suite 200 Naples FL FLORIDA 34103 Director Dr. Marcus Schabacker 4851 Tamiami Trail N Suite 200 Naples FL FLORIDA 34103 Director Frank Pasqualone 4851 Tamiami Trail N Suite 200 Naples FL FLORIDA 34103 Director Bevin O'Niel 4851 Tamiami Trail N Suite 200 Naples FL FLORIDA 34103 Director Michael D. Webb 4851 Tamiami Trail N Suite 200 Naples FL FLORIDA 34103 Director Pharmaceuticals Decline to Disclose 06b false 2022-07-22 false true true true false 0 H.C. Wainwright & Co., LLC 375 None None 430 Park Avenue 3rd Floor New York NY NEW YORK 10022 FL FLORIDA NY NEW YORK false 8617500 8617500 0 Includes 625K shares (or pre-funded warrants) and warrants to buy up to 625K shares at $8.00 per share and warrant for 1 share; warrants to buy up to 375K shares exercise price $7.78/share; 70K placement agent warrants, exercise price $10.00/share. false 2 790950 0 PA received the above cash fee (including certain expense reimbursement) and 70K PA warrants, exercise price $10.00/share (not included in above cash fee) in connection with private placement and a concurrent RD offering (not reported on this Form D). 0 false Enveric Biosciences, Inc. Carter Ward Carter Ward Chief Financial Officer 2022-08-05